T. Rowe Price Associates’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $2.19M | Sell |
|
|||||
|
2020
Q3 | $6.18M | Sell |
|
|||||
|
2020
Q2 | $43.6M | Sell |
|
|||||
|
2020
Q1 | $29.6M | Sell |
|
|||||
|
2019
Q4 | $34.9M | Buy |
|
|||||
|
2019
Q3 | $27.8M | Buy |
|
|||||
|
2019
Q2 | $38.2M | Buy |
|
|||||
|
2019
Q1 | $8.18M | Buy |
|
|||||
|
2018
Q4 | $5.2M | Buy |
|
|||||
|
2018
Q3 | $4.87M | Buy |
|